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This dissertation reports the findings of a study which was carried out in 
the Cape Town City Council area, in order to establish whether the 
offering of rifampicin to household contacts, of patients with meningococcal 
disease, resulted in protection of those contacts against developing the 
disease during a 32 week follow up period. The study took the form of a 
retrospective follow up of 3 350 household contacts of 412 cases notified 
over a 4 year period ( mid 1988-mid 1992) . 
It was found that the offering of rifampicin to the household contacts 
resulted in an odds ratio of not developing meningococcal disease over the 
32 week follow up period of 14, 17 ( SD = 12, 34) . Although there was a 
tendency for contacts who were not offered rifampicin to have been 
younger, and of male gender, when compared to those who were offered 
prophylaxis, these demographic differences were not statistically 
significant at the 0,05 level. Furthermore, three out of the four male 
second cases, all in the younger age group, were in fact offered 
prophylaxis. It seems desirable that prophylaxis should be given as soon 
as possible . 
It is concluded, therefore, that the offering of rifampicin to household 
contacts of patients with meningococcal disease, living under the prevailing 
social circumstances in the Western Cape, has protective benefit for those 
contacts. It is likely that the chemoprophylaxis programme prevented up 
to 88 cases of meningococcal disease over the study period of four years, 
as well as preventing 8 deaths from this disease, in the CCC population. 
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INTRODUCTION TO THE STUDY 
There are two local authorities responsible for the delivery of 
chemoprophylaxis programmes for the prevention of meningococcal disease 
(MCD) in the Cape Peninsula. These authorities, the Western Cape 
Regional Services Council ( WC RSC) and the Cape Town City Council 
(CCC), render their services in two geographically defined separate areas 
of the peninsula. They also follow different chemoprophylaxis policies, 
aimed at reducing the risk of disease for household contacts of patients 
with MCD. These differing policies have differing cost and overtime 
implications. 
Both authorities offer rifampicin chemoprophylaxis to household contacts 
of notified cases of meningococcal disease. In the CCC area this 
prophylaxis is offered as soon as practicable following receipt of a 
notification. This notification may be conveyed by means of a telephone call 
after hours, or on weekends and public holidays, as well as in writing. 
Health inspectors are on call to visit the affected homes and weigh the 
contacts, while doctors are on call to prescribe the rifampicin, in the event 
of an after hours notification . 
During normal working hours, however, nursing staff visit the homes, 
weigh the contacts, issue the prophylaxis, and record all relevant details 
in a case book. These records include the names, genders, and ages of all 
household contacts. Inhabitants of adjacent outbuildings are also offered 
prophylaxis in many cases, but their details are recorded separately. (See 
Appendix 1 for CCC protocols). 
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In the WCRSC, an after hours service is not offered. Nursing staff are 
responsible for all issuing of prophylaxis, and this is normally done only 
during working hours. Furthermore, during the first part of this study 
period, the nursing records were not as complete or as detailed as those 
kept by the CCC staff. For example, names of contacts were not routinely 
recorded, so that retrospective follow up of contacts is not possible. (This 
situation has now changed, and the records are now comparable with those 
of the CCC). 
The WCRSC initiated this study because of concern over the efficacy of 
their policy, and the CCC supported this study because their staff had 
asked for a reduction in their after hours responsibilities. Subsequently, 
the regional infectious diseases committee appealed for information which 
might help to inform a uniform policy for the peninsula. 
The rifampicin chemoprophylaxis programmes for household contacts might 
be criticised on the grounds that there is inadequate evidence for the 
effectiveness of the offering of chemoprophylaxis to household contacts. 
It might be argued that since housing densities in the Western Cape 
Province are so high, and since there is a frequent change of inhabitants 
in the houses of the affected community, any advantages of 
chemoprophylaxis might soon become nullified. 
Furthermore, the view might be expressed that many people, offered 
prophylaxis, do not take the medication they are given. The use of 
rifampicin monotherapy, in an area with a high incidence of tuberculosis, 
might result in the selection of rifampicin resistant strains of 
Mycobacterium tuberculosis. 
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The purpose of this study was thus to attempt to answer two questions for 
the health authorities. These questions were: 
1. Does the offering of rifampicin chemoprophylaxis to household 
contacts of patients with MCD reduce the risk to those contacts of 
becoming diseased? 
2. If the answer to question 1 is yes, is it necessary to offer an after 
hours service? 
This study really only attempts to answer the first question, although the 
second question is also partially addressed. It was decided to scrutinise 
household contacts in a retrospective study to see whether they became 
second cases, and whether the tendency to become a second case was 
associated with not having been offered rifampicin chemoprophylaxis. The 
study was confined to the CCC area since the CCC records were more 
complete at the time the study was initiated. 
THE STUDY AIM 
To estimate the relative risk of secondary attack of meningococcal disease 
among household contacts not offered rifampicin chemoprophylaxis within 
32 weeks of exposure to an index case; based upon data from the Cape 
Town City Council health area for the period July 1 1988 to June 30 1992. 
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THE STUDY OBJECTIVES 
1. To record the names, ages, genders, and addresses of all household 
contacts of notified cases of patients with meningococcal disease, 
resident in the Cape Town City Council area of jurisdiction, during 
the study period. 
2 . To separately record the names and addresses of all notified cases 
of meningococcal disease, resident in the CCC and WCRSC areas 
during the study period, and for 32 weeks thereafter. 
3. For each contact, to record whether or not rifampicin was offered, 
the number of people living in the same dwelling, and the number of 
rooms in the dwelling. 
4. For each CCC case, to record the number of people living in the 
same dwelling, and the number of rooms in the dwelling. 
5. For each CCC case, to record any fatal outcome. 
6. For each CCC case, to record the date of hospital admission, and the 
date on which prophylaxis was given to the household contacts in 
those cases where prophylaxis was offered. 
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DEFINITIONS OF TERMS 
1. Cape Town City Council health area 
This is defined as the geographical area which includes the areas of 
jurisdiction of the CCC health department. This study is confined 
to the CCC area because the pilot study (see Appendix 2) showed 
that the notifications from the WC RSC, especially those from 
Tyger berg Hospital, were incomplete, and the hospital computer 
records were also incomplete. In addition, records of prophylaxis 
given were too vague in most cases to enable the numbers of 
contacts offered prophylaxis to be determined, or to be followed up. 
2. Meningococcal disease 
Since the diagnostic criteria and practices of the different hospitals 
were not the same ( Red Cross Hospital policy was to avoid 
performance of lumbar punctures, for example, where the clinical 
picture was convincing, whereas at Tygerberg Hospital these were 
usually carried out), all cases were accepted as valid where a 
paediatrician, or paediatrics registrar had made a firm diagnosis, 
recorded this in the case notes, and notified the case. 
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3. Second case 
This study is only concerned with second household cases. A second 
case is any case in which the onset of disease was more than 24 hrs, 
and less than 32 weeks, after the admission of a prior case from the 
same dwelling. 
4. Index case 
An index case is defined in relation to a specific second case. It is 
the last case to have occurred in a dwelling before the onset of 
symptoms in the related second case. 
5. Concurrent cases 
Concurrent cases are two or more cases occurring within 24 hours of 
each other, and in persons normally living in the same dwelling. 
(This distinction from second cases is made since it is unlikely that 
the subsequent cases of concurrent cases may be prevented in 
practice). 
6. Household contacts 
Household contacts were defined as all the people stated to be 
normally resident in the same dwelling as a case, and listed as such 
in the nursing record. 
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7. Housing density 
Housing density is defined as the number of people living in a house 
divided by the number of rooms in the house. For the purposes of 
this study "the number of rooms" excludes kitchens and bathrooms. 
INCLUSION CRITERIA 
All notified cases of meningococcal disease, as defined, were eligible for 
inclusion, provided that the patient had been resident in the CCC area for 
at least 36 hours at the time of onset of illness. Only those cases presenting 
to hospital on or after 1 July 1988 and before 30 June 1992 were included. 
All household contacts, listed in the records prepared by the nurses 
during their home visits for these cases, were included as contacts. 
Cases notified for the 32 weeks after 30 June 1992 were separately listed, 
as were all cases from the WCRSC for the same period of 4 years and 32 
weeks. (This was to permit adequate follow up of contacts, to establish 
whether or not they became cases during the 32 week follow up period) . 
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EXCLUSION CRITERIA 
Where cultures of blood or CSF provided documented evidence that the 
patient was suffering from an illness other than meningococcal meningitis, 
then the case was excluded from the study, as well as from the notification 
data. In addition, patients with known complement deficiency, 
splenectomy, or sickle cell anaemia, were excluded, since the epidemiology 
of the infection in such patients is known to follow a different pattern. 
Cases from prisons, school dormitories, hostels and military barracks were 
also excluded, since these would be difficult to incorporate into the study. 
Their inclusion would, for example, distort the concept of room density, 
and may bias the results (large numbers of similar subjects distorting the 
demographic profiles) . Furthermore, the efficacy of rifampicin prophylaxis 
has already been established for such contacts, and is well documented (in 
Cartwright et al, 1989), whereas this study was designed to examine the 
policy of offering chemoprophylaxis to household contacts only. 
Where chemoprophylaxis other than rifampicin had been given to household 
contacts, the case was excluded, since this study was designed to measure 
the efficacy of chemoprophylaxis with rifampicin, compared to no 
chemoprophylaxis. 
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BACKGROUND TO THE PROBLEM 
Prior to 1988, in the CCC area, "close contacts" of patients diagnosed with 
meningococcal disease were offered chemoprophylaxis in the form of oral 
sulphonamides, to be taken as a single dose as soon as possible after 
diagnostic suspicion had been established in the index case. This was done 
in an effort to reduce the risk of subsequent disease among these contacts. 
In 1988, concern with spreading resistance of the meningococcus organism 
to sulphonamides led to a change in policy, and rifampicin became the 
recommended drug for chemoprophylaxis ( Dr S Fisher, personal 
communication; 1989) . 
Some concern was felt by the Medical Officer of Health for the WC RSC, 
because the new drug regime had not been evaluated for efficacy, under 
normal working conditions, for household contacts. Although the published 
evidence from developed countries was strongly suggestive of the wisdom 
of offering rifampicin to household contacts (e.g. Cooke et al, 1989; 
Broome,1986), no follow up study of contacts had ever been published, 
and, furthermore, conditions of overcrowding prevailing in the Western 
Cape were quite different from those to be found in developed countries. 
Some health authorities were also concerned about the use of rifampicin 
because of its cost and because of the danger that clinic personnel might 
abuse the drug, using it more widely to treat other conditions, which might 
lead to increased drug resistance of the ubiquitous tubercle bacillus. 
In addition, studies have suggested that oral rifampicin fails to eradicate 
the meningococcus from the pharynxes of up to 20% of carriers ( Deal and 
Saunders, 1969; Devine et al, 1970; Beam et al, 1971) . As a result, in 1989 
the WCRSC proposed that this study be carried out in their area of 
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jurisdiction, in order to assess the efficacy of the new drug regime, 
something which had not been done before, except in the setting of closed 
communities such as military barracks. Rifampicin had been in use for two 
years, and it was intended to detect whether there had been any change 
in the secondary case attack rate. A previous, unpublished, study, 
carried out by staff of the WCRSC medical staff during the era of 
sulphonamide usage, had failed to identify any second cases in their area 
( personal communication, Dr R. Marshall, 1988) . 
The CCC was also concerned about the efficacy of their chemoprophylaxis 
programme, although for different reasons. Whereas the WC RSC policy was 
to issue chemoprophylaxis to "close contacts" on the first working day 
after notification of an index case, in the CCC the policy was to issue soch 
prophylaxis without delay. This meant that medical staff were reqUired to 
be available after hours and over weekends. Some members of the medical 
staff had questioned whether this was worthwhile. 
A study which was carried out in 1989 (Appendix 2) was intended as a pilot 
study for this present study. It was found that 87% of cases of 
meningococcal disease from the CCC area could be accounted for in the City 
Council notification records. Cases were identified from an examination of 
all public and private sector hospital admission and discharge records in 
the peninsula, as well as burial and cremation registers, and records of 
body removal orders. This established the feasibility of conducting a larger 
study based purely on notification records. 
An attack rate of about 1 secondary case per 100 primary cases was found. 
This rate was similar to reported ratios from Western Europe of about O, 4 
and O. 5 second cases per 100 primary cases ( Cartwright et al, 1989; Cooke 
et al, 1989). These studies were carried out over variable periods of 
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time, generally much shorter than the six month interval allowed in the 
pilot study. Two out of the 3 second cases identified in the pilot study had 
not been offered rifampicin prophylaxis. As expected, the number of 
patients available at that stage was too small to reach any firm conclusions; 
however, the study did indicate the feasibility of the present study which 
used data from four years. 
The regional infectious diseases committee, a forum for officials from all the 
different authorities in the region, was subsequently approached to 
arbitrate by spelling out a uniform policy for the Western Cape. However, 
this committee has been hampered to some extent by the lack of local 
epidemiological research, and the inconclusive findings of the pilot study. 
This study attempts to help resolve the problem by documenting the 
efficacy, if any, of the present CCC policy, whereby household contacts 
of notified cases of meningococcal disease are offered rifampicin 
chemoprophylaxis as soon as possible after receipt of the notification, in 
an attempt to reduce the number of second cases arising among these 
contacts. 
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A REVIEW OF THE RELEVANT LITERATURE 
I: A BRIEF OVERVIEW OF THE CLINICAL PICTURE 
Meningococcal disease may have a very variable presentation, ranging from 
a mild pharyngeal infection, through meningitis, to a fulminant septicaemia 
with high mortality. In addition to the usual signs and symptoms, which 
one might expect from the focus taken by the disease (i.e. meningism, high 
temperature) , there are certain findings thought to be pathognomonic, 
such as a rash which occurs in up to 40% of patients, and which may be 
petechial or purpuric, limited, or generalised; but scrapings from which 
are found on light microscopy to contain gram negative diplococci. For a 
full description of the signs and symptoms see McKendrick, 1977 . 
According to McKendrick there are three clear-cut syndromes 
encountered: 
- meningococcal meningitis, accounting for over 90% of clinical 
illness; 
- acute fulminating septicaemia with a high mortality within hours of 
onset and; 
- chronic meningococcaemia, "a mild low-grade septicaemic illness 
characterised by fever, rashes, and joint pains". 
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Diagnosis is by means of examination of skin scrapings by light 
microscopy, and culture of blood and cerebra-spinal fluid ( CSF) . However, 
in endemic areas, the diagnosis may sometimes be made on clinical grounds 
where skin scrapings are negative and cultures can not be obtained, and 
may be supported by immunological tests on the CSF for antibodies. 
McKendrick has stressed the importance of not delaying treatment, even 
by half an hour, in order to obtain material for culture, if fulminant disease 
is suspected. As a result, even when culture material is obtained, the 
patient may have been pre-treated, and the cultures may then 
subsequently be found to be sterile. Emphasis must therefore be given to 
a high level of suspicion, and sound clinical judgement, in the diagnosis 
of these syndromes, and reliance should not be placed on microbiological 
evidence alone (Farmer, 1993) . 
Case fatality rates vary, with rates of over 50% for fulminant septicaemia, 
10% for meningitis, and very much lower for chronic septicaemia (The 
Editor, British Medical Journal, 1979; Duerden, 1988; Public Health 
Laboratory Service [ PHLS] Meningococcal Infections Working Party, 1989; 
World Health Organisation, 1989. ) 
In South Africa, where "meningococcal infections" have been notifiable 
since 1989 (Minister of National Health and Population development,1989; 
Minister of National Health, 1991), case fatality ratios based on notifications 
have been under O, 1. ( Director General: Department of National Health and 
Population Development [ DNHPD] , 1991a, and 1992) . This compares to 
ratios of between 0,05 and 0,12 for the 8 years preceding 1979 (Director 
General: D NHPD , 1980) . Prior to 1989 only meningococcal meningitis and 
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meningococcal septicaemia were notifiable, and it is unclear whether this 
change in terminology has affected notification practices subsequently 
( Minister of Health, 1979) . 
A pilot study for this study, undertaken in the Cape Peninsula region for 
the year 1988, showed an estimated case fatality rate of 6%, but the rate 
was as high as 12% at Tygerberg Hospital, and 20% for private patients (see 
Appendix 2) ( These are crude rates, not standardised for age and sex) . 
II: EPIDEMIOLOGICAL CONSIDERATIONS 
Meningococcal disease results from infection with certain strains of the 
meningococcus, Neisseria meningitidis, in susceptible individuals, and is 
facilitated by environmental factors. Nasopharyngeal infection with the 
meningococcus is common, and may be as high as 10-25% of certain age 
groups of healthy people ( Cartwright et al, 1987) , usually characterised 
by a harmless commensal relationship. However, in a small proportion of 
infected individuals, a fulminating disease may develop, with a high case 
fatality rate ( Peltola, 1993) . Carriage rates, without the expression of 
disease, of up to 80% have been reported from military barracks (Broome, 
1986). 
An understanding of the factors influencing the expression of disease 
depends upon understanding the interrelationship between agent, host, 
and environment. For this reason, the next part of the literature review 
examines each of these aspects separately and in more detail. 
Page 15 
1. The agent 
Whether or not disease develops in an infected individual depends on the 
virulence of the infecting strain, and on host susceptibility factors, not all 
of which are properly understood. 
Environmental factors may play a role, both in the spread of the infecting 
agent, and in whether or not the virulent organism is able to become 
invasive, causing disease. These factors will be discussed briefly later. 
The meningococcus may be classified into a number of serogroups based on 
the capsular polysaccharide antigens of the organism, and whereas endemic 
disease is commonly associated with infections of serogroups B and C, large 
epidemics, such as occur in the African Sahel, are associated with group 
A infections (Peltola, 1983). The relative importance of the different 
groups in a given community, may change with time, however. 
In England and Wales, whereas disease was mainly due to infections with 
group A organisms early on in this century, group A infections are now 
very uncommon. During the 1970s and 1980s disease was associated with 
group B infections in over two thirds of cases for which isolates had been 
typed. More recently there is an increasing percentage of group C isolates 
reported from those countries (Jones, 1988) . Similar patterns have been 
described from Scotland (Fallon, 1984; 1988) , and Australia (Hansman, 
1988). 
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During the last decade, more refined methods of classifying the 
meningococci have become available, based on clonal typing and a 
combination of monoclonal antibody typing and subtyping. These methods 
have made more sophisticated epidemiological study possible, and have also 
helped to identify strains of particular virulence, explaining in part why 
not all infected hosts become diseased. 
Virulence may therefore be associated with the serogroup, and more 
specifically, with the type or subtype of the infecting organism. It has also 
been claimed that sulphonamide resistance is more common in disease 
producing organisms than in the less virulent isolates (Jones, 1989), 
although this contention remains unproven and controversial. One study 
shows that although isolates from diseased adolescents were more likely 
than not to be sulphonamide resistant, there was no such association for 
isolates from sick babies (Ward et al, 1987). 
In the Western Cape, meningococcal isolates from diseased individuals have 
predominantly been of the B and C serogroups, and although typing has 
been carried out on isolates sent to the Netherlands for several years now, 
epidemiological research has been hampered by the fact that it is not known 
whether specimens submitted to the South African Institute for Medical 
Research have been representative of all isolates causing disease in the 
Peninsula, and many of the isolates have been described as "untypable" 
( Dr G Coetzee: personal communication) . 
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2. The host 
A number of host factors may also play an important role in determining 
whether or not an infection will result in the development of disease. 
Splenectomised persons are more susceptible to fulminant disease ( Holmes 
et al, 1981), and in those areas where the sickle cell gene is prevalent the 
resulting autosplenectomy, which often results by adolescence in persons 
homozygous for this haemoglobinopathy (Fleming, 1982) , may predispose 
such individuals to meningococcal disease. 
The best described predisposing host factor for meningococcal disease is, 
however, the prior existence of complement deficiencies, especially those 
lacking the terminal components of the complement cascade. These patients 
tend to present with recurrent attacks, and to be older than patients with 
normal complement levels at the time of the first attack (See, for example, 
Nicholson and Lepow, 1979; Herva, 1983; Zimran et al, 1987; Hummel et al, 
1987 and; Cooke, Zafar, and Heaney, 1987; Strate, Olsen and Teisner, 
1987). 
Potter et al ( 1990) have described 40 patients with C6 deficiency, 38 of 
whom were from the Western Cape Province. Twenty two of the 24 probands 
presented with meningococcal disease. In their publication, these authors 
show clearly that repeated attacks of MCD may be prevented in these 
subjects by monthly injections of benzathine penicillin, 2, 4 megaunits 
intramuscularly for adults, and proportionately lower doses, but at the 
same interval, for children. 
Page 18 
The subjects of this report were first described by Orren et al (1987), and 
it is interesting that 33 came from 10 families, thus illustrating the familial 
nature of the condition. Potter and coworkers (1993) have subsequently 
shown that the C6 deficiency is associated with a 12, 5-kilobase allele of the 
MspI restriction fragment length polymorphism of the C6 gene, leading to 
total C6 deficiency. 
Age is another host factor which affects a patient's risk of becoming both 
infected, and diseased. There appear to be three patterns in this regard: 
-in Western Europe, North America, and Australasia, where disease 
is mainly associated with groups Band C infection, patients tend to 
be babies and toddlers (de Wals etal, 1981; Broome, 1986; Duerden, 
1988; Hansman, 1988; Communicable Diseases Intelligence, 1993, 
1994). 
- by contrast, in the African Sahel where disease epidemics are 
mainly due to group A infections ( Weekly Epidemiological Record, 
1993), patients tend to be older and of school going age (Greenwood 
and Wall, 1980; Binkin and Band, 1982; Hassan-King, Wall, and 
Greenwood, 1988). 
- the third situation is that which is found in institutions, and the 
military, where the age profiles reflect the profiles of the members 
of the affected community. 
In the Western Cape, the age profiles are similar to those of Western Europe 
(Director General: DNHPD, 1993), as are the groups of disease causing 
isolates ( Dr G Coetzee, personal communication) . 
Page 19 
3. The environment 
Environmental factors which have been implicated with an increased risk 
for Meningococcal disease include household contacts with clinical disease 
(e.g. Cooke et al, 1989; Stuart et al, 1989) . It is perhaps for this reason 
that overcrowding has often been put forward as an important determinant 
of the disease attack rate, allthough overcrowding has not been examined 
as a risk factor for sporadic or primary cases. 
The often reported situation whereby outbreaks occur in military barracks 
and prisons ( See Broome, 1986, for example) has also contributed to the 
belief that crowding of sleeping quarters is a significant environmental 
factor in the incidence of this disease . 
A further environmental factor which has been shown to be important is 
seasonality. In studies from Western Europe and North America, there is 
a definite increase in incidence rates during the damp winter months 
(Broome, 1986; Duerden, 1988). 
In contrast, in the African Sahel, the incidence is greatest during the dry, 
dusty hot weather ( Lapeyssonie, 1963) , so that the significance of the 
seasonality is unclear. In keeping with the apparent association between 
type B or C infection, younger age profile, and winter and spring 
incidence, the Western Cape has persistently shown a predominance of 
cases, with higher incidence rates, during the winter and spring months 
of the year (Director General, DNHPD, 199lb,; 1992,; 1993). 
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Passive smoking and recent upper respiratory infections have both been 
suggested as being associated with increased risk of developing 
meningococcal disease ( Haneberg et al, 1983) , although the study by Cooke 
et al ( 1989) failed to support this, and these theories remain unproven 
(Broome, 1986). 
The term environment, strictly speaking, refers to the human interaction 
with the non-human surroundings, while ecology is used to describe the 
interaction between those non-human elements. From this perspective the 
ecology of the human naso-pharyngeal tract has also been found to play a 
significant role in the environmental disposition towards becoming diseased 
from meningococcal infection. Jones ( 1994) has suggested that infection 
with the influenza virus may in some way promote the development of 
meningococcal disease in subjects infected with the meningococcus. 
A series of studies of meningococcal infection ( Filice et al, 1984; Counts et 
al 1984;) has focused on inhabitants of "skid row" in the United States of 
America, since the incidence of disease is higher in this marginalised 
community than among their fellow citizens. 
Filice and co-workers, in a second published report ( 1985) found that, in 
those skid row inhabitants who did not become ill in a prospective study, 
there was a high prevalence of antibodies to other organisms present 
( Bacillus pumilis and Streptococcus faecalis) . These antibodies cross 
reacted with the group A meningococcal lipo-polysaccharide antigenic 
sites. 
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This finding has been interpreted as suggesting that prior infection with 
certain other organisms may result in acquisition of immunity against 
meningococci, by a mechanism of cross-reactivity. Additional support for 
this theory has come from studies which have demonstrated such cross-
reactivity with various micro-organisms, including Escherichia coli 
(Guirguis et al, 1985; van Alpen, Arends, and Hopman, 1988; Kabat et al, 
1988; Raff et al, 1988) and Neisseria lactamica (Kim, Mandrell, and 
G riffiss, 1989 ) . 
4. Incidence rates 
A report from the World Health Organisation gives the annual incidence 
rate of MCD in France at 3-4 cases per 100 000 (WHO, 1979), although an 
editorial in the Lancet (1978) states that incidence is around 1 per 100 000 
per year in most countries, and as high as 1 per 1 000 in parts of West 
Africa. The Communicable Diseases Intelligence from Australia ( 1994) gives 
the current incidence rates for New Zealand and Australia as 4, 6 and 1, 73 
cases per 100 000 per year respectively. 
In South Africa, the total number of cases reported to the Director 
general: NHPD each year varies between 800 and 1 000, and depending on 
the denominator, this might represent incidence rates of between 2 and 4 
per 100 000 per annum (Director General, DNHPD; 1980, 1993). Up to half 
of these cases are reported from the Western Cape, so that the incidence 
in this region may be as high as 20 or more per 100 000 per year during 
years of high incidence. 
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There is considerable variation in the total number of cases reported from 
the Western Cape, varying between 300 and 500 per year, and although 
some have claimed that patterns and cycles are discernible, such patterns 
have failed to hold up over time, so that the annual variation is currently 
unpredictable. 
A British report ( PHLS Meningococcal Infections Working Party, 1989) cites 
figures from Belgium to suggest that the subsequent incidence rate of 
meningococcal disease is up to 1 200 times higher in household contacts of 
those who have been diagnosed as suffering from a meningococcal illness, 
76 for day care nursery contacts, and 23 for nursery school contacts. 
These studies were conducted before the introduction of chemoprophylaxis 
programmes. 
III: THE CONCEPT OF A SECONDARY OR SECOND CASE 
It has been customary to refer to subsequent cases occurring in close 
contacts as "secondary" cases in the medical literature. Although it might 
be argued that all cases are in fact secondary cases, Broome (1986) points 
out that most patients with menigococcal disease have no known contact 
with ill people. The causative organism has no known reservoir outside 
man, and is in fact ubiquitous among healthy people, especially during 
epidemics. 
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Nevertheless, the organism must have been acquired from some other 
human being, whether healthy or not, in all patients with meningococcal 
disease. For this reason the PHLS Meningococcal Infections Working Party 
prefer to refer to subsequent cases developing in close contacts as 
11 second II cases ( 1989) . The term has not been widely adopted in the 
literature, and in fact the two terms may be used interchangeably. 
IV: STRATEGIES FOR PREVENTION 
1. Vaccination 
Polysaccharide vaccines have been developed against meningococci of the 
groups A, and C, as well as some other pathogenic strains which occur less 
commonly (Galazka, 1982). Unfortunately there is only limited success with 
eradication of the carrier state (Hassan-King, Wall and Greenwood, 1988), 
the vaccine may only protect against disease for up to 5 years, and the 
vaccines are poorly immunogenic in the under 2 year olds who have the 
highest mortality from disease ( PHLS Meningococcal Infections Working 
Party, 1989). 
An additional problem is an unusually high incidence of neurological side 
effects occurring in children receiving the existing vaccines ( Hood and 
Edwards, 1988). Nevertheless, these vaccines have proved very helpful 
in the African Sahel where school-going children are the main disease 
victims, and group A and C epidemics are the norm ( Mohammed and 
Zaruba, 1981; Greenwood and Wali, 1980; Binkin and Band, 1982; Masterton 
et al, 1988). 
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In the Western Cape, however, as in Europe and North America, the under 
5 year olds are the main victims and group Bis the main strain encountered 
in epidemics, so that existing vaccines have little to offer. They might be 
used on older household contacts where the infecting strain is shown to be 
of either group A or C, and may be useful in splenectomised or 
immunocompromised individuals. 
There has been some progress with the development of a vaccine against 
group B virulent strains, with significant elevation of bactericidal 
antibodies in the blood of adult volunteers following immunisation ( Frasch 
et al, 1988). However, the same results have not been reported in children 
as yet, and the protective efficacy in the younger age groups has yet to be 
demonstrated. 
2. Chemoprophylaxis 
The increased risk of illness among close household contacts following 
meningococcal disease ( Meningococcal Disease Surveillance Group, 1976; 
de W als et al, 1981 ) , in one of the members of the household, has led to 
efforts to eliminate the organism from healthy contacts through the use of 
oral and parenteral antibiotics. This is especially important where group 
B organisms are responsible for epidemics of the disease, since no effective 
vaccine against this strain exists. It may also be important where disease 
has been caused by type A or B organisms, however, since immunisation 
may not result in protection for 5 days or more ( Pasteur Merieux, 
undated). 
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Studies have shown a higher than usual pharyngeal carrier state for 
meningococcus among close household contacts, although carriage rates in 
the general public do not appear to be related to the incidence of disease 
(Broome,1986). Antibiotics which have been shown to reduce the 
pharyngeal carriage rates by varying amounts include rifampicin ( Deal and 
Saunders, 1969; Nicolle et al, 1982), sulphonamides and minocycline (Nicolle 
et al, 1982), and erythromycin (Wall and Gruneberg, 1982). 
Recently, ciprofloxacin and parenteral ceftriaxone ( which is safe in 
pregnancy) have also been found to be effective, with almost 100% 
clearance of the carrier state (Schwartz et al, 1988). Unfortunately, there 
is now widespread resistance of organisms to sulphonamides, and trials of 
most of the antibiotics mentioned above, as well as both oral and parenteral 
penicillin, have shown that reductions in carriage rates are not always 
very good (Broome, 1986) . 
The assumption underlying the issue of chemoprophylaxis to close contacts 
is that reduction of the carrier state in close contacts will result in a lower 
secondary attack rate. 
Although this has been shown in closed communities such as military 
barracks, and three studies suggest that it may be true for household 
contacts (Meningococcal Disease Surveillance Group, 1976; Cooke et 
al,1989; Stuart et al,1989), it still remains to be shown whether rifampicin 
chemoprophylaxis is effective in the prevention of secondary cases among 
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household contacts. Various studies have demonstrated that rifampicin 
clears meningococci from infected pharynges by between 70% ( Deal and 
Saunders, 1969) and 96% ( Stuart et al, 1989) . Clearance, in closed 
communities, may persist for at least 5 months (MacIntyre et al, 1993). 
A worrying aspect is that there are emerging reports of meningococci which 
are resistant to rifampicin, especially in military establishments where it 
has been used as a single agent for prophylaxis (Broome, 1986). 
Resistance has also been implicated in the failure of rifampicin 
chemoprophylaxis (Berkey et al, 1988). 
Abramson and Spika ( 1985) have shown that Neisseria meningitidis often 
persists in the upper respiratory tract, after intravenous therapy for 
disease, suggesting that pre-discharge treatment with oral rifampicin or 
parenteral ceftriaxone should be considered as an important part of any 
prophylaxis programme (Schwartz et al,1988). Otherwise the discharged 
patient may simply re-infect household contacts following their 
chemoprophylactic therapy. 
The PHLS Meningococcal Infections Working Party has recommended that 
a two day course of rifampicin be offered to persons "sharing living 
accommodation" with the case, as well as to "mouth kissing contacts of the 
case within the 10 days preceding admission" (1989). They recommend a 
dose of 600mg 12 hrly for 2 days in adults ( lOmk/Kg per dose in children 
aged over 1 year, and 5mg/Kg in infants). 
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Schwartz et al (1988) have shown that a single intramuscular dose of 
ceftriaxone (250mg for adults, 125mg in children) is very effective at 
eliminating the carrier state; on this basis it has been advocated as a means 
of chemoprophylaxis among contacts, especially pregnant women, or in 
cases where compliance with oral therapy may be difficult to ensure. 
It should be pointed out, however, that ceftriaxone has not been evaluated 
in terms of its ability to reduce the secondary attack rate, the drug is 
expensive, and it needs to be given by injection. it is also unclear as to 
why ceftriaxone should be especially indicated for use in pregnant women. 
Rifampicin is not contraindicated for longer term use in pregnant women 
with tuberculosis, so presumably it is also safe for use, over 2 days, as a 
prophylactic agent. 
In South Africa, the Department of National Health and Population 
Development has recommended that chemoprophylaxis be offered to 
household contacts, daycare centre contacts, and close contacts in military 
barracks, prisons, and overcrowded hostels. In addition, hospital contacts 
should be offered prophylaxis if intensive and intimate exposure (mouth to 
mouth resuscitation) has occurred ( Director General: NHPD, 1991b). They 
recommend rifampicin be given in doses which are the same as those 
suggested by the PHLS Meningococcal Infections Working Party. 
The Cape Town City Council also recommends that rifampicin be taken by 
household contacts, but uses a more detailed dosing schedule in which the 
dose is adjusted according to weight ( see Appendix 1) . Where rifampicin 
cannot be taken due to allergy, they recommend doxycycline for non-
pregnant contacts. 
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V EVALUATION OF CHEMOPROPHYLAXIS PROGRAMMES 
Most programmes directed to the household contacts of patients with 
meningococcal disease, where they are in existence, are fairly similar in 
approach. The basic principles have been well described by Cartwright et 
al ( 1989), and do not differ materially from those followed by CCC since 
1988. The principles have been developed on the basis of the ability of a 
drug to clear the meningococcus from infected pharynges. However, no 
published studies have been found in which the efficacy of rifampicin, 
given to household contacts, has been evaluated in practice. 
The two studies which come closest to doing so were both published in the 
British Medical Journal in 1989. In the first, Cooke et al determined the 
incidence of secondary meningococcal infection in household contacts. They 
found that the ratio of second cases to index cases was O, 5%, and that only 
1 out of 7 second cases had taken the rifampicin prophylaxis. This ratio, 
of O, 5%, is considerably lower than the more than 1000 fold attack rate 
documented in the era before chemoprophylaxis was widely offered to 
household contacts. However, these authors did not attempt to identify the 
contacts (about 3 per patient) and follow them up, or to calculate an odds 
ratio. 
In the second paper, Stuart et al assessed effectiveness in terms of the 
number of second cases occurring, and investigated the possible reasons 
for failure of the programme in these cases. They do not appear to have 
questioned the wisdom of the chemoprophylaxis programme, however, and 
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concentrated their attention, rather, on describing the persistence of the 
carrier state in some contacts post-prophylaxis. No attempt was made to 
calculate an odds ratio. 
STATEMENT OF THE PROBLEM AND HYPOTHESIS 
This study attempts to provide an answer to the question of whether or not 
the offering of rifampicin to household contacts of patients, notified as 
having meningococcal disease, will prevent the development of disease in 
some of these contacts, over a 32 week period. Although this is widely 
believed to be so, such a programme has never been critically evaluated for 
efficacy to date, other than in a military setting. The following hypothesis 
is the subject of this study: 
Chemoprophylaxis, with rifampicin, given to household contacts of patients 
with meningococcal disease, prevents second cases of meningococcal 
disease in those contacts during the 32 weeks subsequent to the onset of 
illness in the patient. 
A second problem, that of how soon this prophylactic measure should be 
carried out if it is to be effective, is only a problem if the first hypothesis, 
as stated above, is accepted. This problem, therefore, was not the focus 
of this study, although some insight has been offered by the comparison 
of intervals between sickening of index and second cases, and intervals 




This was a comparitive retrospective study (Fleiss, 1973; page 56) of the 
results of a natural experiment. A pilot study had already established its 
feasibility. 
1. THE STUDY POPULATION: 
The pilot study was carried out just prior to an anticipated epidemic, based 
on historical trends. 147 cases were notified during the pilot study period, 
and so it was anticipated that a four year study would yield about 500 cases 
from the CCC area. Since 3 second cases were identified during the pilot 
study, it was expected that these 500 cases would yield at least 10 second 
cases; probably more, since the full study would involve a more rigorous 
search for cases. The similarity of the findings in the pilot study to those 
reported from Britain (Cooke et al, 1989) lent confidence to these 
expectations. 
Furthermore, in the pilot study, it was found that 2 out of the three second 
cases had not been offered rifampicin. ( The British study reported 6 out 
of 7 second cases had not received rifampicin). Hence it was expected that 
about 10 second cases would be identified, and that of these, 6 would have 
been offered rifampicin. The pilot study also showed that rifampicin was 
not offered to about 10% of contacts. Based on these findings, and on the 
assumption that there would be about 6 household contacts per case, a 4 
year study was planned, since this would be expected to yield an odds ratio 
of about 6, with SD of 3,9. 
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2. THE IDENTIFICATION OF CASES: 
Cases were identified from the CCC notification records. These records 
included cases which were not notified but which were subsequently 
discovered by CCC health inspectors on routine perusal of burial and 
cremation records. Details required for fulfilling the various objectives 
were obtained from patient hospital case notes and from the CCC nursing 
records. WCRSC cases were also listed, in order to identify cases among 
contacts who might have moved to the WCRSC area between the time of 
sickening of their index cases, and falling ill themselves. These case 
details were provided by the WC RSC staff, in the form of a computer print 
out. 
3. THE IDENTIFICATION OF HOUSEHOLD CONTACTS: 
Household contacts were identified from the CCC nursing records. The 
nursing staff opened a booklet for every new case brought to their 
attention, and in this booklet they listed all household contacts by name, 
giving the age and gender for each case, and whether or not prophylaxis 
was issued. Where prophylaxis was not issued, reasons were given. Other 
contacts, such as people living in an outbuilding, or close contacts living 
elsewhere, were separately detailed. 
These records were completed even for those cases where a decision had 
been taken not to offer rifampicin to the contacts (for example, in the case 
of a late notification) . 
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4. THE IDENTIFICATION OF SECOND CASES: 
Particulars, including names and addresses, were written onto a separate 
card for each case. The names of household contacts were written on the 
backs of these cards, along with details of sex, age, and whether or not 
the contact was offered rifampicin. 
This information was encoded (for example, case = l; contact= 2) and 
entered into Lotus 1-2-3 spreadsheets. The entries were then sorted, first 
by surname, and then by street address, and the resulting lists were 
checked to see whether someone encoded as a contact (i.e. code 2) 
subsequently became a case (i.e. code 1). If the interval between two such 
occurrences was less than 224 days (32 weeks) then the case was included 
as a second case. 
5. THE CALCULATION OF HOUSING DENSITIES: 
The number of household inhabitants used was the number of contacts plus 
the case, at the time of the nursing home visit, as recorded in the nursing 
record. 
The number of rooms was recorded by the nurse during this visit for the 
first three years of the study. During the last year of the study, CCC 
policy changed and the nurses were no longer required to record the 
number of rooms in the house. For these cases, a randomly selected list of 
30 houses was drawn up and the CCC nursing staff kindly visited the 
dwellings and recorded the number of rooms retrospectively. 
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In addition, a randomly selected list of 20 houses was drawn up from the 
first three years of the study for repeat visits, in order to record the 
number of rooms for a second time. This data was used to assess the 
repeatability of the records of numbers of rooms. 
6. STATISTICAL ANALYSIS: 
Statistical analysis was carried out manually. Significance of association 
was estimated by calculating the value of Chi square, and 95% confidence 
intervals for the odds ratio was calculated using the method described by 
Fleiss (1973; pages 57-58). Demographic profiles were compared by means 
of the Chi square test. 
Confidence intervals were not calculated for those rates and proportions 
which were based on whole population data, rather than on a sample taken 
from the population. 
The definitions used for the odds ratio, relative risk, risk difference, and 
attributable fraction, were those given by Mausner and Kramer ( 1985) and 
Beaglehole et al ( 1993) . 
Repeatability scores (Kappa), and their standard errors, were calculated 
according to the method described by Fleiss ( 1973) . 
For the purposes of this report the term "standard deviation" (SD) has 
been used for population parameters, while the term "standard error" (SE) 
has been used for sample parameters. 
Page 34 
RESULTS 
The study included the contacts of all notified cases admitted between 
midnight of June 30 1988 and midnight of the 30 June 1992. Notification 
records were scrutinised for patients who became ill between midnight of 
1 July 1988 and midnight of 9 February 1993, to see whether these contacts 
became notified cases. Only contacts of patients notified as having sickened 
in the Cape Town City Council reporting area were included in the study. 
In order to determine whether any of these contacts subsequently became 
cases, their names were checked against the names of notified cases from 
both the Cape Town City Council area and the Western Cape Regional 
Services Council area, in case some contacts had sickened after moving 
between the two areas. 
1. THE NUMBER OF CASES STUDIED 
There were 425 cases recorded for the period. An additional 54 cases 
occurred between the 1 July 1992 and the 9 February 1993. The contacts 
of 421 of the initial 425 cases were eligible for enrolment for scrutiny to 
determine whether they subsequently became cases. Thus, four cases were 




the contacts were issued tetracyclines 
the patient lived in dormitory accommodation 
the patient sickened in the Transkei 
No immunocompromised patients were identified. 
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Three concurrent cases and 6 second cases were recorded. No relapses 
were noted until 1993, and two linked cases were not counted as second 
cases due to excessive time lapses ( 8 months and 18 months respectively). 
Table I gives the age and sex distributions of the cases included in the 
study. 

































There is a tendency for male cases to be younger, overall, than female 
cases; however this difference was not statistically significant ( x2 = 12, 04; 
p=0,1). 
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2. INCIDENCE RATES 
The population of the City of Cape Town is estimated at 1, 16 million, for 
the mid point of the study period ( Medical Officer of Health, Cape Town 
City Council, 1994). 
Using this figure, the incidence of Meningococcal disease is calculated as 
9, 07 cases per 100 000 population per year. 
The incidence among persons living in affected households is 44, 78 cases 
per 100 000 inhabitants per year ( 0, 04478%) . 
The incidence of second cases among the contacts is 291, 8 second cases per 
100 000 contact years. 
The ratio of second cases to index cases is 6: 421 or 1, 425%. 
3. THE CASE FATALITY RATE 
Thirty seven of the 421 cases followed up proved to be fatal, a crude case 
fatality rate of 1 death per 11, 38 cases ( 8, 79%) . The crude case fatality 
rate for males was 17 /239 (7, 11%) and that for females was 19/182 ( 10 ,44%). 
Table II shows the age and sex specific case fatality rates. 
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0,028 0,333 0,368 
If the age specific death rates are compared between the two sexes it 
appears that there is a consistently higher death rate among female 
patients for almost all age groups. However, the differences are only 
statistically significant for cases aged 15 years and over ( 0, 001 < p < 0, 01) . 
4. THE CONTACTS FOLLOWED UP RETROSPECTIVELY 
There were three concurrent cases, and their contacts were not included, 
since this would have resulted in a double counting. There 
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were six second cases, and their contacts were counted again, since they 
were twice placed at risk. In six cases the contacts were not recorded, so 
these could not be included in the study. In two of these cases the contacts 
were noted to have been given prophylaxis at the admitting hospital, but 
details were not available. In three cases the families could not be traced, 
and in one the family refused to deal with the investigating nurse. Thus 
the contacts were recorded for 412 cases; the total number of contacts was 
3350, or 8, 13 contacts per case. Table III shows their demographic 
characteristics. 
TABLE III: THE AGE AND SEX DISTRIBUTION OF CONTACTS 
AGE (YEARS): <1 
MALES: 
1st CONTACTS 44 
































*Refers to the contacts of index cases connected to secondary cases 
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Of the 3350 contacts, 3234 were offered ( and accepted) rifampicin 
chemoprophylaxis, and 116 were either not offered any prophylaxis ( 109) 
or refused to accept it (7). No contacts were offered ceftriaxone, and the 
contacts of the two patients offered tetracycline were excluded from the 
study. The reasons recorded for not issuing prophylaxis were as follows: 
Late notification of index case 70 contacts 
Unknown/unclear 
Contact was pregnant 






Contact on oral contraceptives 4 contacts 
Table IV illustrates the age and sex specific attack rates for second cases 
of meningococcal disease per 100 inhabitants. Although the attack rates are 
higher for males in all age categories, there was no difference between the 
two sexes with respect to the age specific attack rates when submitted to 
statistical testing (X2 = 6,31; p = 0,5). (NOTE: These are not population 
based incidences, merely the attack rates in the affected households, 
calculated to see whether there is any difference within these households 
which might be caused by differences in gender composition of the 
inhabitants. ) 
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TABLE IV AGE AND SEX SPECIFIC ATTACK RATES 
















RATE 53,57 47,73 40,74 31,94 22,22 14,80 5,91 
FEMALES: 












RATE 45,36 46,77 33,33 29,51 14,71 13,64 4,03 
*These numbers reflect the index cases plus their contacts 







Six second cases were identified. Of this number, the contacts of four were 
offered rifampicin, and two were not, according to the records available. 
Ages and genders of these patients were as follows: 
Rifampicin offered: 3 males ( aged 4, 5, 6) 
No rifampicin offered: 1 male ( aged 13) 
1 female ( aged 11) 
1 female (aged 18) 
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Nursing records specifically indicate that prophylaxis had not only been 
issued, but, according to the mothers, it had been taken, for two of the 
second cases ( the 6 year old male and the 11 year old female) to whom 
rifampicin had been offered. 
In the second cases who were not offered prophylaxis, the male patient 
became ill after an interval of three days from the date of onset of illness 
of his index case, while the rifampicin was only subsequently offered to the 
household (four days after the index case sickened). The 18 year old 
female patient was absent from her home on the day prophylaxis was 
issued. 
6. BEING OFFERED RIF AMPICIN AND REMAINING DISEASE FREE 
Table V is a table illustrating the association between being offered 
rifampicin, and remaining disease free during the specified follow up 
period. The 3350 contacts have been sorted into those who were offered 
rifampicin, and those who were not; they have then been further 
categorised depending on whether or not they developed meningococcal 
disease on follow up. 
The "contact years" referred to in the table are based on the fact that 
contacts were followed up for 224 days; illness occurring after this interval 
was not regarded as "second" disease. 
TABLE V 
Page 42 




NO RIF 114(c) 
TOTAL 3344 













ODDS RATIO (OR)= 14,17 (SD= 12,34); RELATIVE RISK (RR)= 13,94 
{where OR= ad/be; and RR= [d/(c+d)]/[b/(a+b)]} 
These numbers represent the relative increase in risk of falling ill if 
not offered rifampicin. OR is an approximation of RR, used in cases 
where precise incidences cannot be calculated, and justified where these 
incidences are very low. 
RISK DIFFERENCE (RD) = 2607, 84 
(2ND CASES/100 000 CONTACT YEARS) 
(Or: 21, 84 second cases prevented per year of the study) 
{where RD = [(d/y)-(b/x)] X 100 000; and the equivalent number of 
cases/year of study= [(RD/100 000) X (a+b+c+d)/4} 
The risk difference estimates the numbers of cases prevented by the 
issuing of rifampicin to household contacts. 
ATTRIBUTABLE FRACTION (AF) = 0,93 
{where AF= [RD/100 000]/[(RD/100 000) + (b/x)]} 
This represents the fraction of second disease among household contacts 
prevented by offering them rifampicin , 
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7. POSSIBLE CONFOUNDING FACTORS 
The association, odds ratio, relative risk, risk difference, and attributable 
fraction, calculated from the data displayed in Table V, are based on crude 
data. Standardisation for age and sex distribution, and for differing 
housing densities, has not been possible, since the number of second cases 
discovered is too low for this to be done. In order to assess the validity of 
the findings a number of comparisons needs to be made. 
7 .1 Age and sex distributions of the index and second cases have 
been displayed in Table I, and the age and sex distribution of the 
contacts has been presented in Table III. From Table III it can be 
shown that households in which second cases occurred, when 
compared to those in which the contacts all remained well, there are 
certain demographic differences: 











Both these differences are statistically significant, p < O, 01. 
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7. 2 Different housing densities may explain why some contacts 
became cases and others did not, independent of the offering of 
prophylaxis. Housing densities were calculated by dividing the 
number of inhabitants by the number of rooms in the dwelling, 
excluding the kitchen and bathrooms(s). Twenty households were 
visited again by the nursing staff, up to five years later, and 
assessed for the number of "rooms" present, in order to validate the 
accuracy or repeatability of the initial estimate taken from nursing 
records. 
It was found that the mean housing density of those contacts who 
were offered rifampicin was 3, 05 persons per room, while that for 
contacts not given rifampicin was lower at 2, 55 per room. Table VII 
shows the results of the repeat recording of the numbers of rooms 
in the houses on a random subsample of 20 dwellings. 
TABLE VII REPEAT ABILITY OF ROOM NUMBERS 





















In addition, it was found that, in a number of instances, the 
nursing staff had visited a household twice for various 
reasons, and independently recorded the number of 
inhabitants. This occurred 14 times, and represents a 
convenience sample which may not be assumed to be random. 
Nevertheless, the information collected provides an 
opportunity to validate the findings in those 14 homes. 
Six of the fourteen homes were those in which secondary cases 
had occurred, 3 were homes of concurrent cases, 2 were 
homes of relapsed cases outside of the study period, and 3 
had independent sources (i.e. hospital records and visiting 
records) of information available. The calculated repeatability 
score was Kappa = 0, 6 763. If this was by chance a 
representative sample, then the standard error would be 
0,0914 and p < 0,0001. 
Of the fourteen cases with repeat visits, the numbers of 
inhabitants had changed in four. One dwelling had reduced 
from 10 inhabitants to 9; one had increased from 8 to 9; one 
from 14 to 15; and one had increased from 7 to 13. 
7. 3 It has already been shown that there are demographic 
differences between households in which second cases 
occurred, and those which remained well. It needs to be 
established whether there were differences between the 
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inhabitants who were offered rifampicin and those not offered 
prophylaxis, since such a difference may also be a confounder 
of the results and invalidate any conclusions. 
A comparison has thus been made between the demographic 
characteristics of contacts who were, and those who were not, 
offered prophylaxis. The findings are presented in table VIII. 
TABLE VIII: DEMOGRAPHIC PROFILES OF INHABITANTS BY 
PROPHYLACTIC STATUS 











NO RIFAMPICIN OFFERED: 
MALES O 2 
FEMALES 2 0 















4 5-9 10-14 15+ 
49 185 183 
56 227 139 
















Comparison of the overall age distributions ( rifampicin vs no 
rifampicin): X2 = 7 ,1 (0,3 < p < 0,5). 
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With regard to overall gender differences, 3, 66% of male contacts 
were not offered rifampicin while 3, 29% of females were not offered 
rifampicin. This difference was not statistically significant (z = 
0,672). 
When the contacts are divided into three groups, namely those under 
10 years old, those aged 10 to 14, and those aged 15 and over, then 
the proportions of male and female contacts offered prophylaxis in 
each of the three groups may be compared, and these figures are 
shown in table IX. 
TABLE IX PROPORTIONS OF CONTACTS NOT OFFERED 













The contents of Table X have been generated from Table VIII. 
Expected numbers have been calculated by applying the male 




ACTUAL VS EXPECTED NUMBERS OF FEMALES BY AGE 
GROUP (EXPECTED BASED ON MALE PERCENTAGES) 









x2 = 5,39; 0,10 > p > o,os 
7. THE DELAY TO PROPHYLAXIS 
A sub study concerned the timing of the offering of rifampicin, relative to 
the date of admission of the cases. These findings are of interest, since, 
if there is a delay between the date of sickening of the cases, and the 
offering of prophylaxis to household contacts, which exceeds the interval 
between the onset of illness of the cases, and onset of illness in any second 
cases, then this study will fail to show the benefits of chemoprophylaxis for 
household contacts. In addition, the staff of the City Council Health 
department requested that this sub study be carried out. 
Unfortunately, this study was not designed to test any hypotheses 
concerning the necessary timing interval. Such a study would require a 
much larger group of contacts in order to ensure large enough groups of 
contacts offered prophylaxis after different delays for comparison of 
outcomes. However, it is of interest to note the time delays recorded for 
delay to prophylaxis in these study subjects, relative to the occurrences 
of known 
Page 49 
second cases, and towards this end the following diagrammatic 
representation of the delays, relative to the delays to onset of second 
ceases, is presented. Date of admission of index cases has been used, as it 
is a documented date, and also since little can be done regarding the 























FIGURE 1: GRAPHIC DEPICTION OF THE DELAYS TO OFFERING OF 
PROPHYLAXIS COMPARED TO ELAPSED INTERVAL 
BETWEEN DATE OF ADMISSION OF INDEX CASES AND 
KNOWN SECOND CASES (CUMULATIVE FREQUENCIES) 
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DISCUSSION 
THE IMPORTANCE OF THE PROBLEM UNDER INVESTIGATION 
Meningococcal disease is a condition which is particularly prevalent in the 
Western Cape Province, with an incidence, based on notifications, of 
approximately 9 cases per 100 000 population per year. This compares to 
the quoted incidence rates of less than 1 in developed countries, and 15 or 
more during epidemics in endemic countries in West Africa. In this study, 
the disease carries a mortality of about 10%, similar to findings reported 
from the United Kingdom. In addition, survivors may experience 
neurological sequelae. 
Studies conducted in Europe, during the pre-antibiotic era, have shown 
that the household contacts of cases of meningococcal disease may have an 
increased risk of developing disease, in excess of 1000 times greater than 
that in the general population. In the post antibiotic era, with the 
introduction of chemoprophylaxis for household contacts, a study from 
Manchester ( Cooke et al, 1989) has shown that the ratio of second to index 
cases was 1: 200. The comparable rate from the present study is higher, at 
2, 9: 200; perhaps partly due to the higher number of household contacts ( 8 
VS 3). 
The problem of meningococcal disease is thus an important problem in the 
Western Cape Province. Furthermore, contacts of MCD patients are at 
considerable risk of becoming diseased, and so it is important to identify 
interventions which might reduce the risk, at least in the short term, in 
this targeted group. 
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Rifampicin chemoprophylaxis, offered to close household contacts as soon 
as possible after the sickening of the index case, is the accepted 
intervention practised in most developed countries, as well as in the area 
where this study was conducted. The practice has, however, never been 
properly evaluated in these countries, and there has been some criticism 
that this intervention may not be effective under the conditions prevailing 
in countries such as South Africa. 
It might be argued, for example, that since numerous studies have 
indicated the carriage of pathogenic strains, in otherwise healthy 
individuals in the community, clearance of the organism from the upper 
airways of household contacts might be superseded by reintroduction of the 
organism to the household. This tendency might be particularly likely in 
a community where there is serious over-crowding of accommodation, and 
a frequent change of address; with new, untreated, inhabitants moving 
into the household at a higher rate than is experienced in, say, Western 
Europe. Housing densities in this study indicated between 2,5 and 3 
inhabitants per room. 
PREVENTION STRATEGIES 
A number of possible strategies, aimed at the reduction of second cases 
among household contacts, have been described. These include 
vaccination, as well as chemoprophylaxis. It is clear, from the review of 
the literature, that vaccination is only of proven benefit where the disease 
causing organisms are not of the type B strain, a situation which is not 
applicable in the Western Cape at present. 
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Furthermore, vaccination may only result in immunity after 5 to 6 days, by 
which time half the second cases might have already occurred, so that 
chemoprophylaxis is still required as an adjunct. It seems that vaccination, 
even in communities where type B organisms are not responsible for 
epidemics, is mainly useful as a tool for aborting epidemics, and not as a 
measure, in isolation, for the protection of household contacts. It is 
reasonable, therefore, for the Local Health Authorities to be placing their 
emphasis on a strategy of chemoprophylaxis in the Cape Town City area. 
CHOICE OF DRUG 
From the literature, it appears that there are 4 currently recognised drug 
options for chemoprophylaxis. The question arises whether the use of 
rifampicin is an appropriate choice in the Western Cape. Each of these is 
considered in turn: 
1. Sulpha drugs have the advantage that they are very cheap. 
However, they are also associated with unacceptable side effects, and may 
be unsuitable for pregnant women at certain stages of gestation. 
Furthermore, there is widespread resistance to these drugs among 
meningococci. They are, therefore, no longer recommended. 
2. Minocycline has been used quite extensively for chemoprophylaxis. 
It is relatively inexpensive, but is contraindicated in children under the 
age of 12, and in pregnant women. Care needs to be taken when this drug 
is given to women on oral contraceptives. Although effective, it has, 
therefore, only limited usefulness. 
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3. Rifampicin is now the most widely used drug for chemoprophylaxis. 
It is more expensive than the two previously mentioned, but the cost is still 
relatively low at under R2, on average, per contact. An advantage is that 
it colours the urine orange, so that patient adherence may be checked on 
second day follow up. The drug is suitable for use in children and in 
pregnant women. Although some studies have indicated that rifampicin may 
clear the nasopharynges of meningococci in only 70% of cases, the study by 
Stuart et al ( 1989) has indicated an efficacy of 96%. One problem is that 
women on oral contraceptives are at increased risk of falling pregnant if 
they take rifampicin concurrently. This problem can be overcome if 
supplementary methods are used during the cycle following its use. A 
further potential problem is that four doses are required, and this may 
result in poor compliance. 
The problem of promoting resistance to rifampicin among tubercle bacilli, 
if the bacilli are exposed to rifampicin monotherapy, has been raised in 
some quarters as an objection to the use of rifampicin for meningococcal 
prophylaxis. The fact that tuberculosis is epidemic in the Western cape has 
lent substance to these fears. 
However, the tubercle bacillus is relatively slow growing, and needs to be 
exposed in large numbers for a period of time if it is to become resistant to 
the drug, and it is unlikely that the use of rifampicin for two days, in 
people who usually do not have active disease, will result in resistance 
emerging. This is borne out by the fact that over the period during which 
rifampicin has been used for prophylaxis in the Western Cape, the 
resistance to rifampicin has declined ( Dr K Weyer, personal 
communication) . 
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4. Ceftriaxone has been shown to clear almost 100% of upper airways of 
meningococci after a single dose. It is safe for use in pregnant women. 
However, there are two major disadvantages. The drug is very much more 
expensive, and it needs to be given by injection. For practical purposes, 
therefore it will be suitable for use only under special circumstances. 
Although ciprofloxacin has been shown to be very effective, and might be 
considered for use in the future,it is currently too expensive in South 
Africa for consideration as an agent for use in large numbers of contacts. 
From the foregoing discussion it appears that the use of rifampicin, as the 
agent for the chemoprophylaxis of meningococcal disease among household 
contacts, by the City Council Health Department, is the most affordable 
and practical choice. 
AGENT, HOST, AND ENVIRONMENT 
None of the cases in this study were noted to be immunocompromised. This 
is surprising, since, in the pilot study, two such patients were identified 
(one from the City Council area). In addition, the gene for sickle cell 
anaemia is prevalent, albeit at a low rate, in this community. 
The occurrence of cross immunity, acquired after exposure to other 
organisms, may partially explain why meningococcal disease is so much 
more common in some communities than others, although the relevance of 
this argument for the high incidence in the Western Cape Province is 
unknown. Social circumstances are at least as poor in other parts of South 
Africa, where the incidence of the disease is much lower. 
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Overcrowding has long been regarded as an important environmental factor 
associated with the occurrence of meningococcal disease. However, this 
association does not hold in isolation in South Africa, where the disease is 
less common, for example, in other urbanised and peri-urban areas with 
similar problems of overcrowding. It is possible that overcrowding plus 
poor ventilation might explain these differences in part. 
In the Western Cape high density housing areas there is a summer problem 
with wind and dust, and a winter problem with rain and cold. These factors 
might encourage people to keep their homes closed up for a major part of 
the year. If this is so, then electrification and dust control measures may 
be important in helping to bring the epidemic under control. 
THE NUMBER OF CASES STUDIED 
There has been a gradual decline in incidence of meningococcal notifications 
since the pilot study was carried out. This may be due to a decline in 
notification practices, but is more likely to reflect actual trends, since the 
time interval is only four years. Nevertheless, this resulted in fewer cases 
( and hence fewer second cases) than expected. 
A notable factor is that, during the time of the pilot study, numerous 
private practitioners were still using sulpha drugs for prophylaxis. No 
case of this happening was found during this study, and it is possible 
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that the pilot study influenced this change of practice, since the 
practitioners concerned were all individually contacted in the course of that 
study. This evidence of a possible effect of being involved in a study 
makes it more likely that the recent decrease in notifications reflects an 
actual decrease in disease, since the pilot study might have influenced 
awareness in the area. 
It would appear that the second cases observed tend to be more likely to be 
male, and that these male cases tend to be younger than their female 
counterparts. This is difficult to explain, since there were no differences 
between the age distributions of male and female contacts. Neither were 
males more common, in general, among the contacts. However, the age 
specific attack rates among inhabitants were consistently higher for males 
in each age category, and were also higher for the younger age categories. 
Thus the noted difference may simply reflect a greater vulnerability to 
disease among young males. This is supported by the different 
demographic profiles of the cases studied. Once again, there was a 
tendency for there to be more, younger, males, among the cases. Although 
these trends are striking, it should be remembered that none was 
statistically significant at the O, 05 level. 
CASE FATALITY RATES 
The case fatality rates are higher than those experienced during the pilot 
study. In general, notifications of deceased patients are less 
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complete than are notifications for survivors. Thus one might expect death 
rates based on notification data to be underestimates. However, in the 
Cape Town City Council area, City Health Department staff regularly 
peruse burial and cremation records, body removal orders, and mortuary 
records, specifically to circumvent this problem. 
Since it is likely that some survivors will not be notified, it is probable that 
these disease specific mortality rates are overestimates in this area. 
Nevertheless, the mortality rate compares to rates quoted in the literature 
for developed countries, so it probably indicates a relative completeness 
of notifications for this disease, confirming the findings of the pilot study. 
Of interest, is that the age specific case fatality rates were so much higher 
in the older age group, especially among women aged 15 and over. 
Meningococcal disease is less common in this age group, and so these 
higher rates may reflect a delay in diagnosis (lower index of suspicion). 
Alternatively, they may indicate that there was some unknown factor which 
affected the level of immuno-susceptibility in these patients, since the 
disease does not ordinarily affect these, older, people. 
THE HOUSEHOLD CONTACTS 
There were 8, 13 household contacts, on average, per notified case. This 
is higher than the 3 contacts per case in the Birmingham study reported by 
Cooke et al ( 1989) . The ratio of these two values is 3, 01. This 
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difference may well explain the approximately 2, 7 fold higher number of 
second cases per index case experienced in Cape Town. The fact that the 
risk of a contact becoming a second case is similar in the two countries 
under very different housing density conditions, lends support to the 
earlier stated opinion that housing densities alone cannot adequately 
explain differences in attack rate. 
THE SECOND CASES 
Fewer second cases were discovered than anticipated. This must be partly 
due to the lower incidence of disease encountered, but may also be due to 
the fact that 96,5% of the contacts received prophylaxis, an increase since 
the pilot study. 
Four of the six second cases were males, and three of these were under 10 
years old; whereas both female patients were over 10 years old. There is 
also a strong suggestion that the index cases were also more likely to be 
young males in spite of the fact that the inhabitants of the affected homes 
were equally likely to be of either gender. 
Three of the four male patients had been offered rifampicin prior to their 
becoming ill, and it was documented that the medication had actually been 
taken in one case, 5 days prior to becoming ill. This observation is of 
relevance later when the demographic characteristics of those offered and 
those not offered prophylaxis are discussed. 
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THE ODDS RATIO FOR REMAINING WELL 
The odds ratio and relative risk are high, at 14, 17 and 13, 94 respectively. 
However, the standard deviation of the odds ratio is also high ( 12, 34) . The 
reasons for this are, that fewer second cases were discovered than 
expected, and the proportion of second cases who were offered prophylaxis 
was O, 66 (expected: 0, 33). The risk difference is equivalent to about 22 
cases a year prevented by the City Council prophylaxis programme. If the 
case fatality rate among these cases had been 10% then about 2 deaths were 
averted each year. 
It is of note that this odds ratio has been calculated for remaining well, 
having been offered rifampicin. No assumption is made as to whether or not 
the rifampicin was actually taken. It is possible that the drugs prescribed 
were not always taken, and in this case the ratio might be an overestimate 
of the advantage from actually taking the medication, unless, of course, 
the degree of non-compliance is the same among those who became second 
cases, and those who did not. 
If the actual taking of rifampicin offers protection against becoming a 
second case, then this last possibility becomes unlikely, and the calculated 
odds ratio must, then, be considered as an overestimate of the advantage 
of the prophylaxis programme. The implication is that the estimate of 22 
cases and 2 deaths averted per year is probably an overestimate. 
As pointed out, at the top of page 58, the risks of a household contact 
falling ill are similar in the Western Cape, and in Britain, populations for 
which a 4 fold difference in general incidence rates is reported. This 
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observation holds for these two populations, which pursue similar 
prophylaxis policies. If it were also true during the pre-prophylaxis era, 
then this would imply that the ratio, between the risks of falling ill, for 
household contacts and the general public, is a function of the general 
incidence rate, so that the ratio of 1 200 reported by de Wals ( 1981) , from 
Belgium, before prophylaxis became routine in that country, implies a 
household incidence of about 3 000 cases per year per 100 000 contacts, if 
no prophylactic measures are taken. 
Applying this ratio to the Western Cape population, one would thus expect 
about (3350/100 000) X (1/4) X (3 000) second cases to occur each year in 
the absence of a prophylaxis programme, or about 25 cases. In fact, 1,5 
cases, on average, were observed per year, suggesting that 23, 5 cases 
were prevented. This compares well with the figure of 21,84 cases 
prevented per year, calculated from the estimated risk difference ( Table 
V), and lends credibility to the findings of this study. 
DEMOGRAPHICS OF HOUSEHOLDS OF SECOND CASES 
Households in which second cases occurred tended to contain younger 
inhabitants, who were more likely to be male. It has already been shown 
that such demographics favour higher attack rates for meningococcal 
disease. This is a potential confounding factor, if in fact there was any 
tendency for such households to be less likely to be offered prophylaxis. 
The contents of Table X suggest that, in fact, persons who were not 
offered prophylaxis were more likely to be males under 10, and females 
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aged 15 and over. The latter observation is explained by the higher 
number of females who were specifically denied prophylaxis on account of 
being pregnant, or because they were taking oral contraceptives. 
However, it is argued that this did not act as a confounding factor, since 
all 3 under 10 year old male second cases had, in fact, been offered 
rifampicin. 
HOUSING DENSITIES 
Housing density is one factor which has been widely accepted as a possible 
association with susceptibility to disease. If, for some reason, persons 
living in more severely overcrowded housing are less likely to be offered 
prophylaxis, then this may be a confounding factor in this study. For 
example, overcrowding may be more severe in poorer areas, and staff may 
be reluctant to visit such areas during times of unrest, or over weekends. 
It was important, therefore, to compare housing densities of persons who 
were, and those who were not, offered rifampicin. In fact, it was found 
that households of persons who were offered rifampicin had higher housing 
densities (3,05 persons per room) than those who were not (2,55). 
It is unlikely, therefore, that housing density was a confounding factor in 
this study, except that the differences may have resulted in an 
underestimate of the odds ratio, in favour of the offering of prophylaxis. 
Nevertheless, as has already been discussed, it is possible that housing 
density on its own is not as important a factor in the aetiology of 
meningococcal disease as is commonly thought. 
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The method used in this study, of calculating the housing densities, was 
rather robust and led to good repeatability. However, more refined 
methods are commonly used, such as weighting the inhabitants for age, and 
counting only those rooms which are stated to be used for sleeping 
purposes. In practice, in a 3 roomed house with 9 inhabitants (8 contacts 
plus the index case) it is likely that all three rooms are used. 
PRE-DISCHARGE PROPHYLAXIS 
It is advocated that patients with meningococcal disease should be given 
pre-discharge rifampicin or ceftriaxone. The reason for this is that the 
parenteral treatment with penicillin, which they usually receive in hospital, 
is poorly effective in clearing the naso-pharyngeal mucosa of pathogenic 
organisms. If patients are not given pre-discharge prophylaxis, the 
danger is that their household contacts may rapidly become recolonised, on 
the patient's return home, thereby nullifying the household 
chemoprophylaxis programme. 
During the time of this study newly diagnosed patients with meningococcal 
disease tended to be transferred early on, from the hospital of initial 
admission, to the City Hospital for further care. At the City Hospital, pre-
discharge prophylaxis was routine. However, at the Red Cross Hospital, 
to which most of the patients initially reported, only about 30% of patients 
were treated in this way, since not all paediatricians believed that it was 
important. 
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It was also shown in the pilot study that Red Cross Hospital staff tended 
to notify cases less often, relying on the staff at the City Hospital to do so. 
It is possible that seriously ill patients, who would be treated entirely at 
the Red Cross Hospital, would thus be less likely to be notified , and would 
be less likely to have been given pre-discharge prophylaxis. Household 
prophylaxis, in the case of non-notified cases, would be less 
comprehensive, since no home visit would be involved. This scenario might 
result in a tendency for the linkage of a higher incidence of second cases 
with a "no prophylaxis" status. If the failure to issue pre-discharge 
prophylaxis is important in the prevention of second cases, then this might 
be a confounding factor in this study. 
Unfortunately, this possible confounding factor has not been ruled out in 
this study, and this is an important limitation. However, it is unlikely that 
the effect of not giving pre-discharge prophylaxis, involving, as it does, 
only one member of the household, would be as significant a factor in the 
aetiology of second cases as the issuing of prophylaxis to all the other 
household members. 
THE DELAY TO PROPHYLAXIS 
This study was not designed to address the importance of timing of 
chemoprophylaxis. However, reference to Figure 1 shows that if 
prophylaxis is to be given at least 24 hrs before the onset of disease, if it 
is to be effective in aborting the disease, then 50% of the second cases 
could only be aborted if rifampicin had been offered within 3 days. In fact, 
only 75% of the prophylaxis issued had been issued by this time. 
Furthermore, second cases continued to occur up to 54 days after the 
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admission of the relevant index case, so that although early intervention 
is important, this does not imply that if an early opportunity has been 
missed, then there is no point in giving prophylaxis to the household 
contacts later on. ( The study reported by Cooke et al, 1989, which made 
use of sub-typing, indicated that in fact, second cases will continue to be 
seen up to a year later, but that there is little advantage to be gained after 
32 weeks, or 224 days) . 
CONCLUSIONS 
1. Rifampicin is a good choice of drug for any chemoprophylaxis 
programme aimed at preventing second cases of meningococcal 
disease among household contacts. It may be given to pregnant 
women, and may also be given to women using oral contraceptives, 
provided they are also counselled to use other, additional, methods 
during their subsequent cycle. 
2. The routine offering of rifampicin to household contacts of patients 
with meningococcal disease results in considerable protection against 
second cases of disease among these contacts, with an odds ratio of 
14, 17 ( SD = 12, 34) . This is in spite of the particular social 
conditions prevailing in the CCC area. 
3. Rifampicin should be given to household contacts as soon as possible 
after suspicion of meningococcal disease in the index patient. 
Furthermore, delays in notification should not preclude the giving 
of prophylaxis to these contacts. 
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RECOMMENDATIONS FOR THE CAPE TOWN CITY COUNCIL 
1. Continue with the policy of 
- encouraging telephonic notification on suspicion of 
meningococcal disease 
- offering rifampicin to household contacts of patients suspected 
of having meningococcal disease 
- offering prophylaxis as soon as possible, including an after-
hours, weekend, and public holiday, service 
2. However, consideration should be given to the following 
modifications of existing policy 
- rifampicin should be offered to pregnant women 
- rifampicin may be offered to women on the oral contraceptive 
pill, along with further advice about additional methods 
(barriers, spermicides, abstinence) to be taken during the 
subsequent cycle 
- consider giving prophylaxis to household contacts when there 
have been delays of 2 months and even up to 224 days 
- nurses should be trained to issue rifampicin to household contacts, 
since this may lead to a reduction of any delays 
3. Further studies are indicated 
- knowledge, attitude, and perception studies of clinicians as a 
prelude to improving early notification of Meningococcal disease 
- the importance of pre-discharge prophylaxis 
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REPORT ON THE PILOT STUDY 
A COPY OF THE ORIGINAL REPORT 
AN ESTIMATE OF THE MINIMUM SECONDARY ATTACK RATE FOR MENINGOCOCCAL INFECTION 
IN THE CAPE TOWN CITY COUNCIL AREA DURING 1988, AND AN INVESTIGATION 
INTO SOME OF THE POSSIB.LE ASSOCIATED FACTORS 
All infections with Neisseria Meningitidis have been acquired some where , 
and so it is necessary to define what is implied by a secondary case. 
For the concept of secondary attack to ha ve meaning in practice, it 
will be l imited to cases occurring amongst the population targetted 
for prophylaxis treatment under existing Cape Town City Counci l policy. 
During 1988 Community Hea lth Sisters , or , as was us u a lly the case , Hea l th 
Inspectors , v isited the homes of all noUfied cases . The quality of 
information , and the scope and de tai l of that information was quite 
outstanding in every case . 
A survey 
In s pectors 
data, case 
orders , was 
of telephonic notifications , written notifications , Health 
reports, hospital admission and di scharge registers , computer 
notes , and registers of deaths , burial orders , and crematio ' 
carried out for the year 1988. 





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Possible secondary cases using the re stricted definition discussed in 
the introduction . 
1. A patient v1ith proven C" deficiency. He and h:i.s contacts were given 
Rifampicin prophylaxi s by C C C and long acting (Depot) Penicillin 
for the patient from Groote Schuur Hospital. He had a second at tack 
four months later. 
2. Two children attending the same creche went down 
ten weeks apart. Although prophylaxi s was given out 
for some reason the second child did not rece _~ve any. 
he wa s absent on the days of the community visit. 
This gives a possible secondary attack rate of 1, 36% . 
with meningitis 
at the creche , 
It is possible 
Confirmation or exclusion of these two cases depends on the results 
of subtyping , which is not yet available; under the criteria in pre-
subtyping days , they would qualify as secondary cases and the expected 
secondary attack rate in Western Countries would be of the order 0 , 3% 
to 0 , 6% according to published data. 
DISCUSSION 
The valid:i t.y of this estimate for secondary attack rate de pends on validi t.y 
of both numerator and denominator . 
An estimate of the 
A mortality of 5% 
Africa according to 
validity of the 
is accepted in 
published data . 
de nominator is given by th e mortality . 
Western countries as we ll as in South 
The mortality rate experienced in 1988 is somewhat highe r. This may 
imply that unnotified cases have not been di scovered by the methods 
u sed, and would s uggest that the denominator shou ld be higher than 147; 
this would reduce the secondary attack rate estimate . 
On the other hand the Cape Peninsula area is in the upswing phase of 
a twelve yearly peak in meningococca1 infections . Pre vious experience 
has shown these upswings to be accompanied by an increase in 1jpe C 
Neisse ri a Meningi tidi s infections and South African epidemiological 
data shows Type C infections to be associated with a higher mortality . 
The numerator should be treated with caution until results of sub-typing 
are available . Howe ver, the actual number of cases is low (2) and if 
this were to only fall by one , there would be a 50% decrease in the 
estimate of secondary attack rate ; it would be unwise, therefore , to 
conc lude anything from this estimate , even if these cases are confirmed . 
In conclusion , the secondary attack rate is wi_ thin r easonable expectations 
and has not been shown to be significantly different from estimates 
in developed Western Countries . 
Whether/ -
Whether this is due to t h e jssu ing of Rifampicin to contacts r emai n s 
lo be seen ; the data for the enlire peninsu l a area ov e r the yea r s 1988 
and 1989 should provjde a suff icie n t ly l arge number of secon da r y cases , 
to make statistical ana lysis o f the impor tance of Rifamp icin i n pre ve n t i ng 
secondary cases , feasi bl e . The r esu l ts of t h is study will not be a v ni l a b l:: 
unti l the end of 1991. 
With rega r d to t he j ssue of ti ming of noti fi cations and pro phylaxi:3 
issue , t h e follo wing comments are off e r e d: 
i . The occurrence of secondary cases up to a year after the pri mary 
case js now very we ll docu mented in t he l i terah1re , and comme n ts 
such as "l a t.e noU fication no prophy l axis issued " are no l onger 
reasonab l e in the l ight of t h is ne w knowl edge . 
ii . A significant nu mber of notifications are be .ing l eft to o f f i cial s 
at City Hospital with r esul'ti ng de l a y of se vera l day s . 
iii. Legal opinion 
for notifjcation 
New l egis l ation 
These facts of 
(Professor Smith , UCT) js that the responsibi l ity 
r ests with t h e doctor who first ma kes t he diag nosis . 
requires telephonic noti f j cation on suspicio~. 
l i f e s h o ul d be con ve y ed · to doctor s , particul a rly 
at Red Cross Hospital. 
iv . In view of the fact that such a high proportion of cases , for one 
reason or another , are at present being notified after se ve r a l 
days have elapsed , no at tempt has been made to analyse these de l ays ; 
Lhe number of cases wh ich are not noti fjed at a ll is a f u rther 
prol.Jlem . Howe ver , as a generalisation , the cases notified to City 
Counci l have invariab l y been fo ll owed up wi th immediate effect 
once the notification (te l ephonic or otherv1ise) is first received . 
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